Cases 21 - 30 of 332
AMGEN INC. et al v. SANDOZ INC. et al
as 1:2023cv02406
Plaintiff:
AMGEN INC. and AMGEN MANUFACTURING, LIMITED
Defendant:
SANDOZ INC., SANDOZ GMBH, LEK PHARMACEUTICALS D.D. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AMGEN INC. et al v. SANDOZ INC. et al
as 2:2023cv02406
Plaintiff:
AMGEN INC. and AMGEN MANUFACTURING, LIMITED
Defendant:
SANDOZ INC., SANDOZ GMBH, LEK PHARMACEUTICALS D.D. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ASTELLAS PHARMA INC. et al v. SANDOZ, INC.
as 2:2023cv01214
Plaintiff:
ASTELLAS PHARMA INC., ASTELLAS US LLC and ASTELLAS PHARMA US, INC.
Defendant:
SANDOZ, INC. and PHV ELIZABETH M. FLANAGAN
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ASTELLAS PHARMA INC. et al v. SANDOZ, INC.
as 3:2023cv01214
Plaintiff:
ASTELLAS PHARMA INC., ASTELLAS US LLC and ASTELLAS PHARMA US, INC.
Defendant:
SANDOZ, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AbbVie Inc. et al v. Alkem Laboratories Limited et al
as 1:2022cv01423
Plaintiff:
AbbVie Inc., AbbVie Ltd. and Neurocrine Biosciences, Inc.
Defendant:
Alkem Laboratories Limited, Hetero Labs Limited, Hetero Labs Limited Unit-V and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Array BioPharma Inc. v. Sandoz Inc.
as 1:2022cv01316
Counter Defendant:
Array BioPharma Inc.
Counter Claimant:
Sandoz Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Biogen Inc. et al v. Sandoz Inc. et al
as 1:2022cv01190
Counter Defendant:
Biogen Inc. and Biogen MA Inc.
Defendant:
Sandoz Inc., Sandoz GmbH, Sandoz International GmbH and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Neurocrine Biosciences, Inc. v. Sandoz Inc. et al
as 1:2022cv01124
Plaintiff:
Neurocrine Biosciences, Inc.
Defendant:
Sandoz Inc., Sandoz AG, Sandoz International GmbH and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ZS Pharma, Inc. et al v. Sandoz Inc.
as 1:2022cv01101
Plaintiff:
ZS Pharma, Inc. and AstraZeneca Pharmaceuticals LP
Defendant:
Sandoz Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Sandoz Inc. v. Amgen Inc. et al
as 2:2022cv05326
Petitioner:
Sandoz Inc.
Defendant:
Amgen Inc. and Amgen Manufacturing Limited
Cause Of Action: 15 U.S.C. § 1125 Trademark Infringement (Lanham Act)
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
